Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet

RxCUI
994007
RxNorm name
Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet
Display name
Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet
Full name
Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9513589d-ef5d-4b8d-a90a-6adb6af2ae11Vimovo 375 MG / 20 MG Delayed Release Oral Tablet [PSN] · esomeprazole 20 MG / naproxen 375 MG Delayed Release Oral Tablet [Vimovo] [SBD] · Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet [SY] · Vimovo 375/20 Delayed Release Oral Tablet [SY]41These highlights do not include all the information needed to use VIMOVO safely and effectively. See full prescribing information for VIMOVO. VIMOVO ® (naproxen and esomeprazole magnesium) DELAYED RELEASE TABLETS Initial U.S. Approval: April 201020110729